Data supplements
Online Appendices
Files in this Data Supplement:
- Appendix 1: Literature search strategies
- Appendix 2: Meta-regression results for all-cause mortality
- Appendix 3: Sensitivity analyses of the relative risk of death from any cause associated with the use of statins in people at low cardiovascular risk
- Appendix 4: Influence analyses for all-cause mortality
In this issue
Article tools
Respond to this article
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
Jump to section
Related Articles
Cited By...
- Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis
- Acute myocardial infarction and influenza: a meta-analysis of case-control studies
- Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis
- Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Low-Risk Diet and Lifestyle Habits in the Primary Prevention of Myocardial Infarction in Men: A Population-Based Prospective Cohort Study
- The Role of Statins in Diabetes Treatment
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
- Statins for primary prevention
- Statins for primary prevention
- The efficacy and cost-effectiveness of statins in low-risk patients